Regulator Filings
Optimi Health Corp. is an end-to-end Canadian-based drug manufacturer and formulator licensed by Health Canada to produce and supply psychedelic substances such as 3,4 Methylenedioxy methamphetamine (“MDMA”) and natural GMP-grade psilocybin, as well as functional mushrooms that focus on the health and wellness markets
The use of psychedelics as a revolutionary treatment for depression and other mental health disorders is gaining significant traction globally. Optimi Health is positioned to deliver cost-effective, GMP-certified MDMA & Psilocybin under Health Canada’s Drug Establishment License to regulated markets around the world
Optimi’s products are grown and manufactured at its two facilities comprising a total of 20,000 square feet in Princeton, British Columbia
For business inquiries please contact:
sales@optimihealth.ca
For media inquiries please contact:
pr@optimihealth.ca
For investor inquiries please contact:
investors@optimihealth.ca
Regulator Filings
Legal Counsel: Norton Rose Fulbright
Auditor: Smythe CPA
Transfer Agent: Endeavor Trust
Corporate Visibility & Investor Relations: Kydder Group
Trading Symbol: CSE: OPTI | OTC:OPTHF |
FRA: 8BN
CUSIP Number: 68405H100
ISIN Number: CA68405H1001
WKN: A2QQEL
Issued & Outstanding: (30/06/2022) 80,451,883
Incorporated: BC / May 27, 2020
Year End: September 30th
